Cryptocurrency & Digital Assets

Connor, Clark & Lunn is capping its popular market neutral funds to protect returns while shuttering its long-short fund in a strategic product shift.

As palates shift, Washington's Tieton Cider Works leverages its farm-to-bottle roots and rapid growth to launch a bone-dry cider for modern purists.

With a key clinical trial complete, Emboline's new funding aims to commercialize a device designed to make popular heart procedures safer for patients.

As the oral stimulant pouch market booms, Doseology Sciences Inc. uplists to the OTCQB to capture U.S. investors and a new wave of consumers.

The UK's fitness landscape is being reshaped. New data reveals a surge in niche sports like Pilates and a boom in independent fitness entrepreneurs.

China's 'Lighting Capital' launches a bold new strategy, inviting 100+ major overseas buyers to its 34th fair to deepen global trade ties.

Advocates call for colorectal cancer screening to start at 45 as cases surge in people under 50, raising questions about Canada's readiness.

Ping An's asset manager bags top awards for innovative and dividend-focused ETFs, highlighting its key role in Asia's evolving investment landscape.

A new framework aims to bridge the gap between open-source software and strict safety standards, potentially revolutionizing industries from auto to medical.

Agfa-Gevaert posts strong Q4 results, but a full-year profit dip reveals a company in deep transformation, betting on digital health and green energy.

Kapsch TrafficCom will integrate TomTom's real-time traffic data into its EcoTrafiX platform, signaling a major shift toward data-driven urban mobility.

At Japan IT Week, ARBOR Technology unveils hardware with NVIDIA Blackwell and AMD EPYC, bringing data center power to the world's harshest environments.

Western Australia mandates a new safety sticker for EVs, a response to soaring adoption rates fueled by attractive novated leasing incentives.

As a $150M expansion nears completion, Louisiana's largest casino bets on a 20-year veteran to steer its financial future and tribal economic goals.

As automation demand soars, ATS Corp. will meet investors to outline its strategy for navigating market shifts and capitalizing on life sciences growth.

With a strong cash position and new leadership, Artiva pivots its AlloNK® cell therapy to autoimmune disease, targeting a pivotal trial for RA in 2026.

Reside's properties win a top Wyndham award for the fourth year, revealing a strategy of powerful partnerships and a new vision for urban living.

Microsoft partners with Neuro-AI pioneer HABS to create AI that understands human cognition, ushering in an era of unprecedented innovation and ethical debate.

As evidence for psychedelic therapy mounts, a key advocacy group brings its case to the UN, challenging decades of prohibitive international drug policy.

The 'Downton Abbey' estate unveils its first flavored gin, a super-premium spirit inspired by its gardens and the sweet wines of Sauternes.